Dichiarazione di accessibilità Salta la navigazione
  • Torna ai siti globali
  • +44 (0)20 7454 5110
  • GDPR
  • Giornalisti
  • Richiedi maggiori informazioni
PR Newswire: news distribution, targeting and monitoring
  • Notizie
  • Prodotti
  • Contatto
When typing in this field, a list of search results will appear and be automatically updated as you type.

Ricerca per il contenuto...

Nessun risultato trovato. Si prega di utilizzare Ricerca avanzata per rivedere la serie completa di contenuti.
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Richiedi maggiori informazioni
    • Telefono

    • +44 (0)20 7454 5110 da 8 AM - 5 PM GMT

    • Contattaci
    • Contattaci

      +44 (0)20 7454 5110
      da 8 AM - 5 PM GMT

  • When typing in this field, a list of search results will appear and be automatically updated as you type.

  • Richiedi maggiori informazioni
  • Giornalisti
  • GDPR
  • Richiedi maggiori informazioni
  • Giornalisti
  • GDPR
  • Richiedi maggiori informazioni
  • Giornalisti
  • GDPR
  • Richiedi maggiori informazioni
  • Giornalisti
  • GDPR

Novatec and Virotech to become Gold Standard Diagnostics Europe
  • USA - Français
  • USA - español
  • Italia - Italiano
  • Nederland - Nederlands
  • Portugal - Português


Notizia fornita da

Gold Standard Diagnostics Europe

24 ago, 2021, 16:02 GMT

Condividi articolo

Share toX

Condividi articolo

Share toX

DIETZENBACH, Germany, Aug. 24, 2021 /PRNewswire/ -- The two German diagnostics companies Novatec Immundiagnostica GmbH and Virotech Diagnostics GmbH are excited to announce that they have joined forces and will now operate together as Gold Standard Diagnostics Europe. Both entities have agreed to consolidate their businesses to better address their partners´ needs and demands. Since the SARS COV 2 outbreak, the companies have been committed to providing the best possible support in the fight against the coronavirus by continuously researching and developing high-quality assays to detect the virus and identify specific mutations.

"Gold Standard Diagnostics Europe unlocks the potential of our combined strengths and establishes the perfect foundation to consistently expand our portfolio. Together, we have the necessary infrastructure to be competitive and deliver innovative diagnostics solutions", says so Artin Papanian, General Manager at Gold Standard Diagnostics Europe. "Our customers will now benefit from the extensive product portfolio that goes hand in hand with the business they are familiar with."

Gold Standard Diagnostics Europe with its headquarters located in Dietzenbach, Germany, is engaged in the development and manufacturing of diagnostic kits for both human and veterinary markets. In addition to focusing on infectious diseases (bacterial, viral, and parasitic diseases), hormones, and autoimmunity, the group also has a broad experience in automation and software to offer a complete panel to diagnosis.

Gold Standard Diagnostics Europe has increased its number of employees to over 200 and continues to grow. With new product development and innovation capabilities, the company is committed to developing, manufacturing and distributing the highest quality assays and services to its vast laboratory network worldwide. The company will continue to devote all its efforts to improving patient care.

Contact Details
Artin Papanian
+49 6074 48760
Gold Standard Diagnostics Europe
[email protected]
www.goldstandarddiagnostics.com

Modal title

Contatta PR Newswire

  • +44 (0)20 7454 5110
    da 8 AM - 5 PM GMT

Siti globali

  • APAC
  • APAC - Cinese tradizionale
  • Asia
  • Brasile
  • Canada
  • Ceco
  • Danimarca
  • Finlandia
  • Francia
  • Germania

 

  • India
  • Indonesia
  • Israele
  • Italia
  • Messico
  • Medio Oriente
  • Medio Oriente - Arabo
  • Olanda
  • Norvegia
  • Polonia

 

  • Portogallo
  • Russia
  • Slovacchia
  • Spagna
  • Svezia
  • Regno Unito
  • Stati Uniti

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921
Siti globali
  • Asia
  • Brasile
  • Canada
  • Ceco
  • Danimarca
  • Finlandia
  • Francia
  • Germania
  • India
  • Israele
  • Italia
  • Messico
  • Medio Oriente
  • Olanda
  • Norvegia
  • Polonia
  • Portogallo
  • Russia
  • Slovacchia
  • Spagna
  • Svezia
  • Regno Uniti
  • Stati Uniti
+44 (0)20 7454 5110
da 8 AM - 5 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • Cookie Settings
Copyright © 2026 Cision US Inc.